Company involving high tech, life sciences and biotech

Austrianova is one organization that does deals that involves high tech, life sciences and biotech. It is accompanied with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based organization that focuses in the insertion of living cells or bacteria in tiny capsules for guarding which is also acknowledged as cell encapsulation technology, isolation, storage and transportation. We were first created in the year 2007 and was recognised in Singapore's greatest exploration biotech hub, Biopolis that has international vision in providing encapsulation services like micro encapsulation.

There is a speedy increasing area of interest in healthy repair and more exact, in the area of neutraceuticals which is the comprehension and use of probiotic bacteria. Thus, probiotics encapsulation was built. The cell-in-a-box technology was created by Austranova with the goal to guard, cut off, contain and transport living cells. This protective creation can be used for various reasons and can be used to probiotics, cosmetics and agriculture environmental protection and screening as well as creating the base of a influential study gear.

In healthcare, this equipment assists facilitates protected attaching of cells or stem cells such as cell therapy, involving them separated from the immune system and permitting long period making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure defends cells in bioreactors and fermentors and at the same time, it make simpler sanitization of bioproducts manufactured from the cells and it shorten constructing rate too.

A wide scale cGMP facility for the making of biomedical grade encapsulated cell items was beforehand fruitfully created and right now, Austrianova is in the journey of developing this experience in the whole of SE Asia. This means the use of cell-in-a-box was quite a victory for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow inferior quantities of chemotherapy to be used more efficaciously without the usual enervating side effects. The encapsulated cell are positioned, using supraselective catheterisation, into blood vessels that goes to the tumor where they locally change a chemotherapeutic product to its tumor toxic product.

Come to our page for additional details: Microbeads, Cell Therapy , Cell Encapsulation Technology.